Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin.
Ontology highlight
ABSTRACT: Nutritional supplements which include natural antitumoral compounds could represent safe and efficient additives for cancer patients. One such nutritional supplement, Ocoxin Oral solution (OOS), is a composite formulation that contains several antioxidants and exhibits antitumoral properties in several in vitro and in vivo tumor conditions. Here, we performed a functional genomic analysis to uncover the mechanism of the antitumoral action of OOS. Using in vivo models of acute myelogenous leukemia (AML, HEL cells, representative of a liquid tumor) and small-cell lung cancer (GLC-8, representative of a solid tumor), we showed that OOS treatment altered the transcriptome of xenografted tumors created by subcutaneously implanting these cells. Functional transcriptomic studies pointed to a cell
SUBMITTER: Perez-Pena J
PROVIDER: S-EPMC6566638 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA